Exabis Library
Welcome to the e-CCO Library!
P779: Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P779: COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS ANTI-TNFs IN ULCERATIVE COLITIS BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNFα (EVOLVE-IBERIA STUDY)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P779: Extra intestinal manifestations and other comorbidities in Crohn’s disease and Ulcerative colitis are equally likely to appear before IBD diagnosis: a Danish nationwide registry study from 2003 to 2015
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P780 Proteinuria is associated with the development of Crohn’s disease: a nationwide population-based study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P780: 3-oxo-C12:2-HSL, a new N-acyl-homoserine lactone identified in gut ecosystem exerts an anti-inflammatory effect and does not modify paracellular permeability
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P780: Interchangeability by a biosimilar of infliximab: What do patients think?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P780: Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010–2011 cohorts
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P780: Prognosis and optimal treatment for 5-aminosalicylic acid-intolerant patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P781 Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P781: Biological treatment and surgery in IBD patients stratified by age groups
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P781: Defining the economic burden of venous thromboembolism after surgery for inflammatory bowel disease in the USA: a national inpatient sample study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P781: The stability of the fecal microbiota in Crohn's disease patients with changing disease course
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P781: Treatment outcome of tofacitinib dose reduction to 5 mg BID vs remaining on 10 mg BID in patients with Ulcerative Colitis who were in stable remission on 10 mg BID: Updated 30-month data from the double-blind, randomised RIVETING study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P782 Immune status to viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P782: A new compatibility test for donor selection for faecal microbiota transplantation in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P782: Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P782: Natural history of acute severe ulcerative colitis in elderly: A population-based study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P782: Ustekinumab in Ulcerative colitis: a real-life effectiveness study across multiple Belgian centers (SULTAN)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P783 Non-alcoholic fatty liver disease and advanced liver disease in patients with inflammatory bowel disease: prevalence and risk factors
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P783: Ciprofloxacin resistance in ESBL producing enterobacteriaceae colonizing the gut in IBD patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM